spacer
spacer

PDBsum entry 4f52

Go to PDB code: 
protein metals Protein-protein interface(s) links
Cell cycle/ligase/signaling protein PDB id
4f52

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
258 a.a.
84 a.a.
85 a.a.
523 a.a.
Metals
_ZN ×6
PDB id:
4f52
Name: Cell cycle/ligase/signaling protein
Title: Structure of a glomulin-rbx1-cul1 complex
Structure: Cullin-1. Chain: a, c. Fragment: c-terminal domain, delta whb domain, unp residues 411-690. Synonym: cul-1. Engineered: yes. Mutation: yes. E3 ubiquitin-protein ligase rbx1. Chain: b, d. Fragment: unp residues 5-108.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: cul1. Expressed in: escherichia coli. Expression_system_taxid: 511693. Gene: rbx1, rnf75, roc1. Expression_system_taxid: 562. Gene: glmn, fap48, fap68, vmglom.
Resolution:
3.00Å     R-factor:   0.222     R-free:   0.289
Authors: D.M.Duda,J.L.Olszewski,B.A.Schulman
Key ref: D.M.Duda et al. (2012). Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface. Mol Cell, 47, 371-382. PubMed id: 22748924
Date:
11-May-12     Release date:   19-Sep-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q13616  (CUL1_HUMAN) -  Cullin-1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
776 a.a.
258 a.a.*
Protein chain
Pfam   ArchSchema ?
P62877  (RBX1_HUMAN) -  E3 ubiquitin-protein ligase RBX1 from Homo sapiens
Seq:
Struc:
108 a.a.
84 a.a.
Protein chain
Pfam   ArchSchema ?
P62877  (RBX1_HUMAN) -  E3 ubiquitin-protein ligase RBX1 from Homo sapiens
Seq:
Struc:
108 a.a.
85 a.a.
Protein chains
Pfam   ArchSchema ?
Q92990  (GLMN_HUMAN) -  Glomulin from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
594 a.a.
523 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 2: Chains A, C, E, F: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 3: Chains B, D: E.C.2.3.2.27  - RING-type E3 ubiquitin transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
   Enzyme class 4: Chains B, D: E.C.2.3.2.32  - cullin-RING-type E3 NEDD8 transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-[NEDD8-protein]-yl-[E2 NEDD8-conjugating enzyme]-L-cysteine + [cullin]- L-lysine = [E2 NEDD8-conjugating enzyme]-L-cysteine + N6-[NEDD8- protein]-yl-[cullin]-L-lysine
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.

 

 
Mol Cell 47:371-382 (2012)
PubMed id: 22748924  
 
 
Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface.
D.M.Duda, J.L.Olszewski, A.E.Tron, M.Hammel, L.J.Lambert, M.B.Waddell, T.Mittag, J.A.DeCaprio, B.A.Schulman.
 
  ABSTRACT  
 
The approximately 300 human cullin-RING ligases (CRLs) are multisubunit E3s in which a RING protein, either RBX1 or RBX2, recruits an E2 to catalyze ubiquitination. RBX1-containing CRLs also can bind Glomulin (GLMN), which binds RBX1's RING domain, regulates the RBX1-CUL1-containing SCF(FBW7) complex, and is disrupted in the disease Glomuvenous Malformation. Here we report the crystal structure of a complex between GLMN, RBX1, and a fragment of CUL1. Structural and biochemical analyses reveal that GLMN adopts a HEAT-like repeat fold that tightly binds the E2-interacting surface of RBX1, inhibiting CRL-mediated chain formation by the E2 CDC34. The structure explains the basis for GLMN's selectivity toward RBX1 over RBX2, and how disease-associated mutations disrupt GLMN-RBX1 interactions. Our study reveals a mechanism for RING E3 ligase regulation, whereby an inhibitor blocks E2 access, and raises the possibility that other E3s are likewise controlled by cellular proteins that mask E2-binding surfaces to mediate inhibition.
 

 

spacer

spacer